Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.
Int J Pharm. 2023 Jan 5;630:122462. doi: 10.1016/j.ijpharm.2022.122462. Epub 2022 Nov 30.
Int J Pharm. 2023.
PMID: 36462739
Free article.
In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Csige K, Szabó JP, Kálmán-Szabó I, Dénes NS, Szikra D, Képes Z, Opposits G, Méhes G, Kertész I, Fenyvesi F, Trencsényi G, Hajdu I.
Csige K, et al.
Int J Pharm. 2022 Sep 25;625:122132. doi: 10.1016/j.ijpharm.2022.122132. Epub 2022 Aug 24.
Int J Pharm. 2022.
PMID: 36028082
Free article.
Item in Clipboard
In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography.
Trencsényi G, Kis A, Szabó JP, Ráti Á, Csige K, Fenyvesi É, Szente L, Malanga M, Méhes G, Emri M, Kertész I, Vecsernyés M, Fenyvesi F, Hajdu I.
Trencsényi G, et al. Among authors: csige k.
Int J Pharm. 2020 Feb 25;576:118954. doi: 10.1016/j.ijpharm.2019.118954. Epub 2020 Jan 11.
Int J Pharm. 2020.
PMID: 31935470
Item in Clipboard
Cite
Cite